NCT02334033

Brief Summary

Hypertension is an underdiagnosed and undertreated disease in real-life. Blood pressure and kidney functions are known to be closely related. Increased serum level of Cystatin C, a sensitive biomarker for renal function, seems to predict adverse cardiovascular events. The investigators aimed to evaluate the predictive value of serum Cystatin C for control of hypertension in a community-based study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
903

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2014

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2015

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

January 2, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 8, 2015

Completed
Last Updated

January 27, 2015

Status Verified

January 1, 2015

Enrollment Period

1 year

First QC Date

January 2, 2015

Last Update Submit

January 24, 2015

Conditions

Uncontrolled Hypertension

Keywords

hypertensionblood pressurecystatin Creal-lifekidney

Outcome Measures

Primary Outcomes (1)

  • The prevalence of uncontrolled hypertension

    The outcome measures will be obtained at the time of enrollment

    At subject enrollment

Secondary Outcomes (1)

  • The value of cystatin C to determine uncontrolled hypertension

    At subject enrollment

Interventions

otherOTHER

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults residing in both rural and urban communities

You may qualify if:

  • Individuals who accept to participate to the survey
  • \> 18 years

You may not qualify if:

  • Individuals who are not able to complete the questionnaire
  • Individuals who didn't give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara University School Of Medicine, Department of Cardiology

Ankara, 06230, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

January 2, 2015

First Posted

January 8, 2015

Study Start

January 1, 2014

Primary Completion

January 1, 2015

Study Completion

January 1, 2015

Last Updated

January 27, 2015

Record last verified: 2015-01

Locations

TU(1)